Sortera Bio is a multidisciplinary biotechnology company based in Cambridge UK that specialises in the discovery and development of innovative biopharmaceuticals. At the core of our approach is Deep Screening, a proprietary high-throughput experimental platform that revolutionises the screening process by enabling the rapid, parallel evaluation of 10⁸ to 10⁹ sequence-function pairs. This powerful technology generates vast datasets that provide a comprehensive understanding of the global fitness landscape for biologics, delivering both positive and negative results—both critical for the effective application of machine learning in drug discovery. Our platform enables breakthroughs in a matter of days, achieving what previously took months or even years.